PlumX Metrics
Embed PlumX Metrics

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life

PLoS ONE, ISSN: 1932-6203, Vol: 17, Issue: 4 April 2022, Page: e0265153
2022
  • 25
    Citations
  • 0
    Usage
  • 31
    Captures
  • 4
    Mentions
  • 16
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    25
  • Captures
    31
  • Mentions
    4
    • News Mentions
      4
      • News
        4
  • Social Media
    16
    • Shares, Likes & Comments
      16
      • Facebook
        16

Most Recent News

Stigma in Nonalcoholic Fatty Liver Disease Little Studied

Almost 7 in 10 patients with this relatively new syndrome report experiencing stigmatization in their daily lives. Medscape Medical News

Article Description

Background and aims Stigmatization is a well-documented problem of some diseases. Perceived stigma is common in alcohol-related liver disease and hepatitis C, but little information exists on stigma in patients with non-alcoholic fatty liver disease (NAFLD). Aim of the study was to investigate frequency and characteristics of perceived stigma among patients with NAFLD. Methods One-hundred and ninety-seven patients seen at the liver clinic were included: a study group of 144 patients with NAFLD, 50 with cirrhosis (34 compensated, 16 decompensated), and a control group of 53 patients with alcohol-related cirrhosis. Demographic, clinical, and laboratory data were collected. Quality-of-life was assessed by chronic liver disease questionnaire (CLDQ). Perceived stigma was assessed using a specific questionnaire for patients with liver diseases categorized in 4 domains: stereotypes, discrimination, shame, and social isolation. Results Perceived stigma was common in patients with NAFLD (99 patients, 69%) and affected all 4 domains assessed. The frequency was slightly higher, yet not significant, in patients with NAFLD cirrhosis vs those without (72% vs 67%, respectively; p = 0.576). In patients without cirrhosis perceived stigma was unrelated to stage of disease, since frequency was similar in patients with no or mild fibrosis compared to those with moderate/severe fibrosis (66% vs 68%, respectively). There were no differences in perceived stigma between patients with compensated cirrhosis and these with decompensated cirrhosis. Among patients with cirrhosis, stigmatization was more common in alcohol-related vs NAFLD-cirrhosis, yet differences were only significant in two domains. In patients with NAFLD, perceived stigma correlated with poor quality-of-life, but not with demographic or clinical variables. Conclusions Perceived stigmatization is common among patients with NAFLD independently of disease stage, is associated with impaired quality-of-life, and may be responsible for stereotypes, discrimination, shame, and social isolation, which may affect human and social rights of affected patients.

Bibliographic Details

Carol, Marta; Pérez-Guasch, Martina; Solà, Elsa; Cervera, Marta; Martínez, Sara; Juanola, Adrià; Ma, Ann T; Avitabile, Emma; Napoleone, Laura; Pose, Elisa; Graupera, Isabel; Honrubia, Maria; Korenjak, Marko; Torres, Ferran; Ginès, Pere; Fabrellas, Núria; LiverHope Consortium Investigators

Public Library of Science (PLoS)

Multidisciplinary

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know